KINGSTON, R.I., May 4, 2018 — This is a remarkable time for research on Alzheimer’s disease. New avenues of discovery are cause for hope that scientists are closer than ever to finding effective therapies. One of the most promising areas receiving increased attention is neuroinflammation — the way brain tissue reacts to injuries such as high blood pressure, high blood sugar and other conditions.
Researcher W. Sue T. Griffin, who has made key discoveries about the connection between neuroinflammation and Alzheimer’s disease, will discuss her latest findings at the University of Rhode Island on Tuesday, May 15, at 5 p.m.
Sponsored by the George & Anne Ryan Institute for Neuroscience at URI, the free talk, “Alzheimer’s Disease: The Inflammation Connection,” is geared toward non-scientists and is open to the public. Griffin is a member of the National Scientific Advisory Board of the Ryan Institute.
The event will be held in Room 105 at the Beaupré Center for Chemical and Forensic Science, 140 Flagg Road, Kingston campus. Parking is available in the adjacent Lot 13. For more information, call (401) 874-4471 or email email@example.com.
The Ryan Institute brings together researchers, clinicians, and private partners at URI and beyond who share a common interest in finding new treatments and cures for neurodegenerative diseases such as Alzheimer’s, ALS and Parkinson’s disease. Institute researchers concentrate on underexplored approaches to these diseases such as the role of blood vessels, the immune system and inflammation in the origin and course of brain disease.